therapeutic areas -
Ferring Pharmaceutical has a strong reputation within the international gastroenterology community, being able to offer effective medications for the treatment of diseases of the gastrointestinal tract. Ferring’s aim is to be a key player within the field.
Through a committed research division, Ferring continually strives to improve the treatment of long-term and life threatening gastrointestinal problems. Our research program has achieved to develop many effective products.
The products help to improve the quality of life for people suffering from inflammatory bowel diseases such as Ulcerative Colitis. Our vasoactive product is for life threatening diseases such as bleeding esophageal varices and, in some markets, hepatorenal syndrome. Our dual action laxative medication helps patients prepare for gastro-intestinal examinations.
Ferring IPC Gastroenterology division, headed by Ferring USA, participate in setting up and running clinical trials for new compounds as well as for improvement of our already marketed products within the area of gastroenterology. This covers all steps from identifying unmet medical needs and hosting international clinical expert meetings to writing protocols and running global clinical trials. Knowledge sharing and collaboration with international experts within the field ensures Ferring’s research is always on the forefront ethically and scientifically.
The message has been sent
Your friend has been sent the following email: